🔗 Share this article

This year's prestigious award in Physiology or Medicine has been awarded for revolutionary findings that clarify how the immune system attacks harmful infections while protecting the body's own cells.

A trio of esteemed scientists—from Japan Shimon Sakaguchi and American scientists Mary Brunkow and Dr. Ramsdell—share this accolade.

The work uncovered unique "sentinels" within the immune system that remove malfunctioning immune cells that could harming the body.

The discoveries are now enabling innovative treatments for autoimmune diseases and malignancies.

The laureates will share a prize fund worth 11m SEK.

Crucial Findings

"The work has been essential for comprehending how the body's defenses operates and why we don't all suffer from serious self-attack conditions," commented the head of the Nobel Committee.

This trio's studies explain a fundamental mystery: In what way does the immune system protect us from numerous infections while leaving our healthy cells unharmed?

The body's protection system employs immune cells that search for signs of infection, even viruses and germs it has never encountered.

Such cells utilize detectors—known as recognition units—that are generated randomly in countless combinations.

That provides the immune system the capacity to fight a wide array of threats, but the unpredictability of the process unavoidably produces immune cells that can target the body.

Protectors of the Body

Scientists previously knew that a portion of these problematic white blood cells were destroyed in the thymus—where immune cells develop.

The latest award honors the discovery of regulatory T-cells—known as the body's "security guards"—which patrol the system to disarm other immune cells that assault the healthy cells.

We know that this process fails in self-attack conditions such as type-1 diabetes, MS, and RA.

A prize committee stated, "The findings have laid the foundation for a new field of investigation and spurred the creation of new treatments, for instance for cancer and autoimmune diseases."

In malignancies, T-regs prevent the system from attacking the tumor, so research are aimed at reducing their numbers.

For self-attack disorders, trials are testing boosting regulatory T-cells so the body is not being harmed. A comparable method could also be effective in minimizing the chances of transplanted organ rejection.

Innovative Studies

Professor Shimon Sakaguchi, of a Japanese institution, conducted experiments on mice that had their immune gland removed, leading to autoimmune disease.

The researcher demonstrated that introducing immune cells from other animals could stop the illness—suggesting there was a system for blocking immune cells from harming the host.

Mary Brunkow, affiliated with the a research center in a US city, and Fred Ramsdell, now at a biotech firm in San Francisco, were investigating an genetic immune disorder in mice and humans that led to the identification of a genetic factor critical for how T-regs function.

"Their pioneering research has revealed how the immune system is controlled by T-reg cells, stopping it from accidentally targeting the body's own tissues," commented a prominent physiology specialist.

"This work is a remarkable illustration of how fundamental physiological research can have far-reaching consequences for public health."